Haus D’ Longevity | Coming Soon – The Future of Healthspan
- Patient Portal
- Membership
Longevity
Regenerative Medicine
Regenerative medicine encompasses a range of procedures, biologic products, and emerging approaches, each with its own considerations, supporting evidence, potential risks, and regulatory status.
At Haus D’ Longevity, we believe those distinctions matter. Our approach centers on the individual — your health, your goals, the available evidence, and the information you need to make an informed decision.
Regenerative Medicine at Haus D’ Longevity
Platelet-Rich Plasma (PRP)
Platelet-rich plasma (PRP) is prepared from a sample of your own blood. The blood is processed to concentrate platelets within the plasma, creating a preparation that may be used in specific procedures.
How PRP is prepared and used depends on the procedure being considered. Your provider will explain the proposed application, how the procedure is performed, potential risks and limitations, available alternatives, and what may reasonably be expected based on your individual circumstances.
Understanding Emerging Regenerative Approaches
01
Stem Cell and Cell-Based Products
The term “stem cell therapy” can refer to different cell-based products and procedures. These products may differ significantly in their source, processing, composition, proposed use, supporting evidence, and regulatory status.
Understanding the specific product being considered is essential. Your provider can help you understand these distinctions, the available evidence, potential risks and limitations, and questions to consider when evaluating a cell-based product or procedure.
02
Exosome Products
Exosomes are small extracellular vesicles involved in communication between cells and continue to be an area of scientific research.
Products marketed as containing exosomes may differ in their source, composition, preparation, proposed use, supporting evidence, and regulatory status. There are currently no FDA-approved exosome products.
Understanding the specific product, available evidence, potential risks and limitations, and regulatory status is important when evaluating products marketed as exosome-based therapies.
Your Health. Your Goals.
Interest in regenerative medicine may begin with something you’d like to address, a treatment you’ve heard about, or simply curiosity about what’s possible.
Your provider can review your relevant health history, discuss your goals, and help you understand the options that may appropriately be considered — as well as when another approach may make more sense.
Understand Before
You Decide.
For any regenerative procedure or biologic product you’re considering, it is important to understand:
- The specific product, material, or procedure involved
- Where it comes from and how it is prepared
- How the procedure is performed and by whom
- Its proposed or authorized use, as applicable
- Its regulatory status
- What the available evidence does — and does not — establish
- Potential risks and limitations
- Recovery and follow-up, when applicable
- Available alternatives, including choosing not to proceed
A consultation gives you time to ask questions, understand the specific option being discussed, and consider your choices before deciding whether moving forward is right for you.
Frequently Asked
Questions
Is regenerative medicine one type of treatment?
No. Regenerative medicine is a broad term encompassing different procedures, biologic products, and areas of research. The evidence, risks, regulatory status, and potential applications can vary substantially between them.
How do I know whether a regenerative procedure may be appropriate for me?
Your provider can consider the specific procedure alongside your health history, goals, available evidence, potential risks, and reasonable alternatives before making a recommendation.
What results should I expect?
Expectations depend on the specific procedure and your individual circumstances. Your provider can explain what the available evidence supports, potential limitations, and where uncertainty may remain.
Are all regenerative medicine products FDA-approved?
No. Products and procedures described as regenerative medicine can have very different regulatory statuses. Some products marketed as regenerative therapies are not FDA-approved. Understanding the specific product and its regulatory status is an important part of making an informed decision.
Does a consultation mean I have to move forward with treatment?
No. A consultation is an opportunity to understand your options, ask questions, discuss alternatives, and decide whether you want to proceed.